title: Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care targets.
abstract: The Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 goals propose that 90% of all people living with HIV should know their HIV status, 90% of those diagnosed should receive antiretroviral therapy (ART), and 90% of those should have durable viral suppression. We have estimated the continuum of HIV care for the entire HIV-1-infected population in Sweden.
  
  
  
  The Swedish InfCare HIV Cohort Study collects viral loads, CD4 counts, and viral sequences, along with demographic and clinical data, through an electronic clinical decision support system. Almost 100% of those diagnosed with HIV infection are included in the database, corresponding to 6946 diagnosed subjects living with HIV-1 in Sweden by 31 December 2015.
  
  
  
  Using HIV surveillance data reported to the Public Health Agency of Sweden, it was estimated that 10% of all HIV-infected subjects in Sweden remain undiagnosed. Among all diagnosed patients, 99.8% were linked to care and 97.1% of those remained in care. On 31 December 2015, 6605 of 6946 patients (95.1%) were on ART. A total of 6395 had been on treatment for at least 6 months and 6053 of those (94.7%) had a viral load < 50 HIV-1 RNA copies/mL.
  
  
  
  The 2014 UNAIDS/WHO 90-90-90 goals for HIV care means that > 73% of all patients living with HIV should be virologically suppressed by 2020. Sweden has already achieved this target, with 78% suppression, and is the first country reported to meet all the UNAIDS/WHO 90-90-90 goals.
authors.affiliation: Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Gisslén
authors.affiliation: Department of Infectious Diseases, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
authors.forename: V
authors.initials: V
authors.lastname: Svedhem
authors.affiliation: Department of Infectious Diseases/Venhälsan, South General Hospital, Stockholm, Sweden.
authors.forename: L
authors.initials: L
authors.lastname: Lindborg
authors.affiliation: Department of Infectious Diseases, Skåne University Hospital, Malmö, Sweden.
authors.forename: L
authors.initials: L
authors.lastname: Flamholc
authors.affiliation: Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
authors.forename: H
authors.initials: H
authors.lastname: Norrgren
authors.affiliation: Department of Infectious Diseases, Sunderby Hospital, Luleå, Sweden.
authors.forename: S
authors.initials: S
authors.lastname: Wendahl
authors.affiliation: Public Health Agency of Sweden, Solna, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Axelsson
authors.affiliation: Department of Infectious Diseases, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.|Department of Clinical Microbiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
authors.forename: A
authors.initials: A
authors.lastname: Sönnerborg
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis* / Q000188:drug therapy*; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D015331:Cohort Studies; D003955:Diagnostic Tests, Routine; D004363:Drug Utilization; D006801:Humans; D000072230:Sustained Virologic Response; D013548:Sweden; D014480:United Nations; D014944:World Health Organization
chemical_list: D044966:Anti-Retroviral Agents
keywords: HIV; antiretroviral treatment; continuum of care; treatment cascade